Literature DB >> 23516982

Controlling natural killer cell responses: integration of signals for activation and inhibition.

Eric O Long1, Hun Sik Kim, Dongfang Liu, Mary E Peterson, Sumati Rajagopalan.   

Abstract

Understanding how signals are integrated to control natural killer (NK) cell responsiveness in the absence of antigen-specific receptors has been a challenge, but recent work has revealed some underlying principles that govern NK cell responses. NK cells use an array of innate receptors to sense their environment and respond to alterations caused by infections, cellular stress, and transformation. No single activation receptor dominates; instead, synergistic signals from combinations of receptors are integrated to activate natural cytotoxicity and cytokine production. Inhibitory receptors for major histocompatibility complex class I (MHC-I) have a critical role in controlling NK cell responses and, paradoxically, in maintaining NK cells in a state of responsiveness to subsequent activation events, a process referred to as licensing. MHC-I-specific inhibitory receptors both block activation signals and trigger signals to phosphorylate and inactivate the small adaptor Crk. These different facets of inhibitory signaling are incorporated into a revocable license model for the reversible tuning of NK cell responsiveness.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23516982      PMCID: PMC3868343          DOI: 10.1146/annurev-immunol-020711-075005

Source DB:  PubMed          Journal:  Annu Rev Immunol        ISSN: 0732-0582            Impact factor:   28.527


  207 in total

1.  Activation or tolerance of natural killer cells is modulated by ligand quality in a nonmonotonic manner.

Authors:  Jayajit Das
Journal:  Biophys J       Date:  2010-10-06       Impact factor: 4.033

2.  Mutual activation of natural killer cells and monocytes mediated by NKp80-AICL interaction.

Authors:  Stefan Welte; Sabrina Kuttruff; Inja Waldhauer; Alexander Steinle
Journal:  Nat Immunol       Date:  2006-10-22       Impact factor: 25.606

Review 3.  Up on the tightrope: natural killer cell activation and inhibition.

Authors:  Lewis L Lanier
Journal:  Nat Immunol       Date:  2008-05       Impact factor: 25.606

4.  Natural killer cell tolerance in mice with mosaic expression of major histocompatibility complex class I transgene.

Authors:  M H Johansson; C Bieberich; G Jay; K Kärre; P Höglund
Journal:  J Exp Med       Date:  1997-08-04       Impact factor: 14.307

5.  Rapid lytic granule convergence to the MTOC in natural killer cells is dependent on dynein but not cytolytic commitment.

Authors:  Ashley N Mentlik; Keri B Sanborn; Erika L Holzbaur; Jordan S Orange
Journal:  Mol Biol Cell       Date:  2010-05-05       Impact factor: 4.138

6.  Minimal requirement for induction of natural cytotoxicity and intersection of activation signals by inhibitory receptors.

Authors:  Yenan T Bryceson; Hans-Gustaf Ljunggren; Eric O Long
Journal:  Blood       Date:  2009-07-23       Impact factor: 22.113

7.  DNAX accessory molecule-1 mediated recognition of freshly isolated ovarian carcinoma by resting natural killer cells.

Authors:  Mattias Carlsten; Niklas K Björkström; Håkan Norell; Yenan Bryceson; Thorbald van Hall; Bettina C Baumann; Mikael Hanson; Kjell Schedvins; Rolf Kiessling; Hans-Gustaf Ljunggren; Karl-Johan Malmberg
Journal:  Cancer Res       Date:  2007-02-01       Impact factor: 12.701

8.  Proinflammatory cytokine signaling required for the generation of natural killer cell memory.

Authors:  Joseph C Sun; Sharline Madera; Natalie A Bezman; Joshua N Beilke; Mark H Kaplan; Lewis L Lanier
Journal:  J Exp Med       Date:  2012-04-09       Impact factor: 14.307

9.  Functional dichotomy in natural killer cell signaling: Vav1-dependent and -independent mechanisms.

Authors:  F Colucci; E Rosmaraki; S Bregenholt; S I Samson; V Di Bartolo; M Turner; L Vanes; V Tybulewicz; J P Di Santo
Journal:  J Exp Med       Date:  2001-06-18       Impact factor: 14.307

10.  Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule.

Authors:  Cristina Bottino; Roberta Castriconi; Daniela Pende; Paola Rivera; Marina Nanni; Barbara Carnemolla; Claudia Cantoni; Jessica Grassi; Stefania Marcenaro; Nicolas Reymond; Massimo Vitale; Lorenzo Moretta; Marc Lopez; Alessandro Moretta
Journal:  J Exp Med       Date:  2003-08-11       Impact factor: 14.307

View more
  485 in total

1.  Effects of aging on human leukocytes (part I): immunophenotyping of innate immune cells.

Authors:  Ulrik Stervbo; Sarah Meier; Julia Nora Mälzer; Udo Baron; Cecilia Bozzetti; Karsten Jürchott; Mikalai Nienen; Sven Olek; Dominika Rachwalik; Axel Ronald Schulz; Julian Marcel Waldner; Avidan Neumann; Nina Babel; Andreas Grützkau; Andreas Thiel
Journal:  Age (Dordr)       Date:  2015-09-01

Review 2.  CD8⁺ T Cell-Independent Immune-Mediated Mechanisms of Anti-Tumor Activity.

Authors:  G Elizabeth Pluhar; Christopher A Pennell; Michael R Olin
Journal:  Crit Rev Immunol       Date:  2015       Impact factor: 2.214

Review 3.  Boosting vaccine efficacy the natural (killer) way.

Authors:  Carolyn E Rydyznski; Stephen N Waggoner
Journal:  Trends Immunol       Date:  2015-08-10       Impact factor: 16.687

4.  Human dNK cell function is differentially regulated by extrinsic cellular engagement and intrinsic activating receptors in first and second trimester pregnancy.

Authors:  Jianhong Zhang; Caroline E Dunk; Melissa Kwan; Rebecca L Jones; Lynda K Harris; Sarah Keating; Stephen J Lye
Journal:  Cell Mol Immunol       Date:  2015-08-17       Impact factor: 11.530

5.  Systems Analysis of Immunity to Influenza Vaccination across Multiple Years and in Diverse Populations Reveals Shared Molecular Signatures.

Authors:  Helder I Nakaya; Thomas Hagan; Sai S Duraisingham; Eva K Lee; Marcin Kwissa; Nadine Rouphael; Daniela Frasca; Merril Gersten; Aneesh K Mehta; Renaud Gaujoux; Gui-Mei Li; Shakti Gupta; Rafi Ahmed; Mark J Mulligan; Shai Shen-Orr; Bonnie B Blomberg; Shankar Subramaniam; Bali Pulendran
Journal:  Immunity       Date:  2015-12-15       Impact factor: 31.745

Review 6.  Tissue-Resident Cytolytic Innate Lymphocytes in Cancer.

Authors:  Briana G Nixon; Ming O Li
Journal:  J Immunol       Date:  2018-01-15       Impact factor: 5.422

7.  IL-12, IL-15, and IL-18 pre-activated NK cells target resistant T cell acute lymphoblastic leukemia and delay leukemia development in vivo.

Authors:  Margherita Boieri; Aina Ulvmoen; Amanda Sudworth; Clare Lendrem; Matthew Collin; Anne M Dickinson; Lise Kveberg; Marit Inngjerdingen
Journal:  Oncoimmunology       Date:  2017-01-17       Impact factor: 8.110

Review 8.  CS1 (SLAMF7, CD319) is an effective immunotherapeutic target for multiple myeloma.

Authors:  Joseph D Malaer; Porunelloor A Mathew
Journal:  Am J Cancer Res       Date:  2017-08-01       Impact factor: 6.166

9.  T-cell immunoglobulin and ITIM domain (TIGIT) receptor/poliovirus receptor (PVR) ligand engagement suppresses interferon-γ production of natural killer cells via β-arrestin 2-mediated negative signaling.

Authors:  Man Li; Pengyan Xia; Ying Du; Shengwu Liu; Guanling Huang; Jun Chen; Honglian Zhang; Ning Hou; Xuan Cheng; Luyu Zhou; Peifeng Li; Xiao Yang; Zusen Fan
Journal:  J Biol Chem       Date:  2014-05-09       Impact factor: 5.157

10.  Cognate HLA absence in trans diminishes human NK cell education.

Authors:  Vanessa Landtwing; Ana Raykova; Gaetana Pezzino; Vivien Béziat; Emanuela Marcenaro; Claudine Graf; Alessandro Moretta; Riccarda Capaul; Andrea Zbinden; Guido Ferlazzo; Karl-Johan Malmberg; Obinna Chijioke; Christian Münz
Journal:  J Clin Invest       Date:  2016-08-29       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.